BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 349438)

  • 21. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative expressed estrogenicity of oral contraceptives.
    Rooks WH; Kugler SL; Dorfman RI
    Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestational potency of oral contraceptives: a polemic.
    Edgren RA
    Int J Fertil; 1978; 23(3):162-9. PubMed ID: 40889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oral contraceptives on mononuclear cell cholesteryl ester hydrolase activity.
    Hagemenas FC; Yatsu FM; Manaugh LC
    Lipids; 1980 Jan; 15(1):39-44. PubMed ID: 7360009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of oral contraceptives on circulation immune response. I. Effect of combination type contraceptives.
    Rangnekar KN; Rao SS; Joshi UM
    Contraception; 1974 Nov; 10(5):517-26. PubMed ID: 4448065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral contraceptives on plasma androgenic steroids and their precursors.
    Fern M; Rose DP; Fern EB
    Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
    Potera C; Rose DP
    Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tri-Norinyl and Ortho-Novum 7/7/7--two triphasic oral contraceptives.
    Med Lett Drugs Ther; 1984 Oct; 26(672):93-4. PubMed ID: 6384752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
    Spellacy WN; Ellingson AB; Tsibris JC
    Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial control: a comparative study of three oral contraceptives.
    Talwar PP; Dingfelder JR; Ravenholt RT
    Int J Gynaecol Obstet; 1976; 14(5):385-9. PubMed ID: 15901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.